baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,LOC,cds,ncbi_id,protein,protein_id,location,gbkey,saccver,SPID,gene.Uni,species,pident,length,mismatch,gapopen,qstart,qend,sstart,send,evalue,bitscore,Entry,Reviewed,Entry Name,Protein names,Gene Names,Organism,Length,Gene Ontology IDs,Gene Ontology (biological process),Gene Ontology (GO),Gene Ontology (molecular function),Gene Ontology (cellular component),Developmental stage,Induction,Tissue specificity
1064.20221850826,-0.619252571078573,0.163024552897965,-3.79852335167055,1.45560716979316e-4,0.0470712857188949,LOC132713118,lcl|NW_026860702.1_cds_XP_060551573.1_32941,132713118,inhibitor of growth protein 5-like isoform X1,XP_060551573.1,"complement(join(56191..56292,57207..57372,58447..58537,61732..61849,64755..64921,65632..65703,67640..67676))",CDS,sp|Q8WYH8|ING5_HUMAN,Q8WYH8,ING5,HUMAN,61.2,250,86,2,1,750,1,239,1.34e-98,290,Q8WYH8,reviewed,ING5_HUMAN,Inhibitor of growth protein 5 (p28ING5),ING5,Homo sapiens (Human),240,GO:0000123; GO:0001558; GO:0003682; GO:0005634; GO:0005654; GO:0006275; GO:0006355; GO:0006473; GO:0008270; GO:0008285; GO:0035064; GO:0043065; GO:0045926; GO:0048144; GO:0048147; GO:0050793; GO:0051726; GO:0070776; GO:0097190; GO:0140889; GO:1903706; GO:2000278; GO:2001235,apoptotic signaling pathway [GO:0097190]; DNA replication-dependent chromatin disassembly [GO:0140889]; fibroblast proliferation [GO:0048144]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706],histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; DNA replication-dependent chromatin disassembly [GO:0140889]; fibroblast proliferation [GO:0048144]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706],chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270],histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,TISSUE SPECIFICITY: Down-regulated in bone marrow cells in acute myeloid leukemia patients as compared with normal bone marrow cells. {ECO:0000269|PubMed:21750715}.
230.874426951374,-1.03092217855227,0.274090879784721,-3.76124218128668,1.69071631882053e-4,0.0480890218009203,LOC132713474,lcl|NW_026860819.1_cds_XP_060552068.1_33387,132713474,uncharacterized protein LOC132713474,XP_060552068.1,"complement(join(83978..85705,86137..86308,89495..89618,90060..90250,97961..98064))",CDS,sp|P46012|YKI5_CAEEL,P46012,YKI5,CAEEL,32.407,108,66,4,127,429,41,148,1.23e-7,59.3,P46012,reviewed,YKI5_CAEEL,Uncharacterized protein C01G6.5,C01G6.5,Caenorhabditis elegans,952,GO:0005634; GO:0010468,regulation of gene expression [GO:0010468],nucleus [GO:0005634]; regulation of gene expression [GO:0010468],NA,nucleus [GO:0005634],NA,NA,NA
81.4122693622883,1.19676017508557,0.279695016241989,4.27880407439989,1.8790016637824e-5,0.0142381351073111,LOC132715395,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151.276855203886,-0.874805565095651,0.233732024569888,-3.74277152095636,1.8200170252312e-4,0.0480890218009203,LOC132717148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62.4577601530176,1.45538995561076,0.32927827950123,4.41993914027761,9.87287017812078e-6,0.00940642041882937,LOC132720785,lcl|NW_026862958.1_cds_XP_060560982.1_41412,132720785,malignant fibrous histiocytoma-amplified sequence 1 homolog isoform X3,XP_060560982.1,"join(96304..96486,97840..98715,100385..101114,101709..101947,102341..102485,103149..103169,104696..104876,105653..105808,106267..106399,112912..113083,113571..113738,115932..116008)",CDS,sp|Q9Y4C4|MFHA1_HUMAN,Q9Y4C4,MFHA1,HUMAN,24.128,688,379,19,271,2124,130,744,1.86e-34,147,Q9Y4C4,reviewed,MFHA1_HUMAN,Malignant fibrous histiocytoma-amplified sequence 1 (Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1),MFHAS1 MASL1,Homo sapiens (Human),1052,GO:0005525; GO:0005737; GO:0006954; GO:0030218; GO:0031625; GO:0034121; GO:0034136; GO:0034137; GO:0034144; GO:0035556; GO:0043030; GO:0045087; GO:0046330; GO:0050728; GO:0051721; GO:0051897; GO:0070374; GO:1900181; GO:1900745,erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]; regulation of toll-like receptor signaling pathway [GO:0034121],cytoplasm [GO:0005737]; GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625]; erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]; regulation of toll-like receptor signaling pathway [GO:0034121],GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625],cytoplasm [GO:0005737],NA,"INDUCTION: Up-regulated during erythroid cells differentiation (at protein level) (PubMed:23327923). Up-regulated upon Toll-like receptor TLR2 stimulation (PubMed:26599367). Up-regulated in macrophages upon M. tuberculosis infection (PubMed:20616063). Up-regulated upon sepsis (PubMed:26599367). Up-regulated by glucose (PubMed:29168081). {ECO:0000269|PubMed:20616063, ECO:0000269|PubMed:23327923, ECO:0000269|PubMed:26599367, ECO:0000269|PubMed:29168081}.","TISSUE SPECIFICITY: Ubiquitously expressed. Overexpressed in malignant fibrous histiocytomas (PubMed:9973190). Expressed in red blood cells (at protein level) (PubMed:23327923). {ECO:0000269|PubMed:23327923, ECO:0000269|PubMed:9973190}."
101.887562683926,0.924554186242007,0.246538731143179,3.75013768406663,1.76737501848205e-4,0.0480890218009203,LOC132720882,lcl|NW_026863016.1_cds_XP_060561095.1_41508,132720882,large ribosomal subunit protein mL50-like,XP_060561095.1,"complement(join(5832..6164,7093..7225,7996..8135,8852..8929))",CDS,sp|Q8N5N7|RM50_HUMAN,Q8N5N7,RM50,HUMAN,34.653,101,63,1,235,528,58,158,3.84e-13,68.2,Q8N5N7,reviewed,RM50_HUMAN,"Large ribosomal subunit protein mL50 (39S ribosomal protein L50, mitochondrial) (L50mt) (MRP-L50)",MRPL50,Homo sapiens (Human),158,GO:0005739; GO:0005743; GO:0005762; GO:0005829; GO:0032543,mitochondrial translation [GO:0032543],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543],NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739],NA,NA,NA
357.717212083836,-0.876880948881854,0.230264778681993,-3.80814188735686,1.40014930965798e-4,0.0470712857188949,LOC132722155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
177.943208831158,-0.746913858029817,0.189181875480271,-3.94812587693005,7.87653886144472e-5,0.0397896488150649,LOC132722184,lcl|NW_026863477.1_cds_XP_060562615.1_42872,132722184,flap endonuclease GEN homolog 1-like,XP_060562615.1,"complement(join(165437..165513,165561..166118,166815..166943,168320..168381,169378..169514,170467..170550,171118..171220,171397..171581,172292..172378,173372..173461,174495..174696,175285..175445))",CDS,sp|Q17RS7|GEN_HUMAN,Q17RS7,GEN,HUMAN,44.421,475,183,12,1,1221,1,462,7.61e-105,341,Q17RS7,reviewed,GEN_HUMAN,Flap endonuclease GEN homolog 1 (EC 3.1.-.-),GEN1,Homo sapiens (Human),908,GO:0000287; GO:0000400; GO:0000724; GO:0005654; GO:0005813; GO:0008821; GO:0010824; GO:0017108; GO:0031297; GO:0042803; GO:0071139; GO:0071140; GO:0090267,double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of DNA recombination intermediates [GO:0071139]; resolution of mitotic recombination intermediates [GO:0071140],centrosome [GO:0005813]; nucleoplasm [GO:0005654]; 5'-flap endonuclease activity [GO:0017108]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of DNA recombination intermediates [GO:0071139]; resolution of mitotic recombination intermediates [GO:0071140],5'-flap endonuclease activity [GO:0017108]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],centrosome [GO:0005813]; nucleoplasm [GO:0005654],NA,NA,NA
95.3734573227872,1.65184205940264,0.362715259917956,4.55410136252959,5.26099857917791e-6,0.00753311421898238,LOC132723766,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
108.269260734883,-1.11789596310838,0.249694546294863,-4.47705398334274,7.56801179695935e-6,0.00917545750263352,LOC132725056,lcl|NW_026864281.1_cds_XP_060566034.1_45972,132725056,serine-rich adhesin for platelets-like isoform X3,XP_060566034.1,"complement(join(197269..197356,200555..200719,201286..201480,202044..202223,203064..203215,203511..203651,204347..204457,205056..209594,209956..210071,213052..213249,213542..213735,214886..214964,216025..216042,217508..217559,218212..218478,218754..218893,219547..219662,220784..220944,226650..226844,233372..233503,234695..234910))",CDS,sp|E9Q3S4|M3K19_MOUSE,E9Q3S4,M3K19,MOUSE,64.388,278,97,2,6592,7419,1030,1307,1.07e-96,347,E9Q3S4,reviewed,M3K19_MOUSE,Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (SPS1/STE20-related protein kinase YSK4),Map3k19 Ysk4,Mus musculus (Mouse),1311,GO:0004676; GO:0004677; GO:0004679; GO:0004694; GO:0004709; GO:0004711; GO:0005524; GO:0035175; GO:0035402; GO:0035403; GO:0035979; GO:0044022; GO:0044023; GO:0044024; GO:0044025; GO:0072354; GO:0072371; GO:0072518; GO:0106310; GO:0140823; GO:0140855; GO:0140857; GO:1990244,NA,3-phosphoinositide-dependent protein kinase activity [GO:0004676]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; histone H2AS1 kinase activity [GO:0044024]; histone H2AS121 kinase activity [GO:0072371]; histone H2AT120 kinase activity [GO:1990244]; histone H2AXS139 kinase activity [GO:0035979]; histone H2BS14 kinase activity [GO:0044025]; histone H2BS36 kinase activity [GO:0140823]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; histone H3S57 kinase activity [GO:0140855]; histone H3T11 kinase activity [GO:0035402]; histone H3T3 kinase activity [GO:0072354]; histone H3T45 kinase activity [GO:0140857]; histone H3T6 kinase activity [GO:0035403]; histone H4S1 kinase activity [GO:0044023]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; ribosomal protein S6 kinase activity [GO:0004711],3-phosphoinositide-dependent protein kinase activity [GO:0004676]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; histone H2AS1 kinase activity [GO:0044024]; histone H2AS121 kinase activity [GO:0072371]; histone H2AT120 kinase activity [GO:1990244]; histone H2AXS139 kinase activity [GO:0035979]; histone H2BS14 kinase activity [GO:0044025]; histone H2BS36 kinase activity [GO:0140823]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; histone H3S57 kinase activity [GO:0140855]; histone H3T11 kinase activity [GO:0035402]; histone H3T3 kinase activity [GO:0072354]; histone H3T45 kinase activity [GO:0140857]; histone H3T6 kinase activity [GO:0035403]; histone H4S1 kinase activity [GO:0044023]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; ribosomal protein S6 kinase activity [GO:0004711],NA,NA,NA,NA
124.790312295968,-1.05051640358681,0.262582689833362,-4.00070699349404,6.31535168067673e-5,0.033290140772402,LOC132727157,lcl|NW_026864884.1_cds_XP_060568564.1_48249,132727157,cytosolic carboxypeptidase-like protein 5 isoform X8,XP_060568564.1,"complement(join(32815..32833,33150..33252,44988..45217,47027..47358,51534..51772,53817..54016,54594..54778,56314..56449,57068..57228))",CDS,sp|B2GV17|CBPC5_RAT,B2GV17,CBPC5,RAT,65.972,144,49,0,1,432,460,603,7.78e-55,201,B2GV17,reviewed,CBPC5_RAT,Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5),Agbl5 Ccp5,Rattus norvegicus (Rat),832,GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686,C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634],NA,NA,NA
179.53958170679,0.560390820649022,0.131996863097626,4.24548589639249,2.18120229271132e-5,0.0155558215275482,LOC132728236,lcl|NW_026852917.1_cds_XP_060569828.1_4940,132728236,elongin-C,XP_060569828.1,"join(17159..17327,20274..20322,23590..23731)",CDS,sp|P83941|ELOC_RAT,P83941,ELOC,RAT,95.413,109,5,0,31,357,4,112,8.6e-76,222,P83941,reviewed,ELOC_RAT,Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Stromal membrane-associated protein SMAP1B homolog) (Transcription elongation factor B polypeptide 1),Eloc Tceb1,Rattus norvegicus (Rat),112,GO:0001222; GO:0006367; GO:0006511; GO:0016567; GO:0030674; GO:0030891; GO:0031466; GO:0032968; GO:0044877; GO:0070449; GO:0140958,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; transcription corepressor binding [GO:0001222]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511],protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; transcription corepressor binding [GO:0001222],Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; VCB complex [GO:0030891],NA,NA,NA
651.512189406939,-0.541610557034656,0.139737982583295,-3.87590078962112,1.06230964439081e-4,0.045998007602122,LOC132729677,lcl|NW_026865596.1_cds_XP_060571471.1_50869,132729677,transcriptional regulator ATRX-like isoform X3,XP_060571471.1,"join(65394..65450,66628..66771,67084..67212,68178..68240,73643..77098,77967..78104,78974..79543,80789..80905,83562..83663,86782..86898,87910..87998,88889..88981,95011..95073,95463..95539,96114..96211)",CDS,sp|O43303|CP110_HUMAN,O43303,CP110,HUMAN,38.378,185,99,3,4558,5112,790,959,5.26e-27,124,O43303,reviewed,CP110_HUMAN,Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa) (CP110) (Cep110),CCP110 CEP110 CP110 KIAA0419,Homo sapiens (Human),1012,GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007099; GO:0032053; GO:0032465; GO:0032991; GO:0045724; GO:0051298; GO:1902018,centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465],centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465],NA,centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; protein-containing complex [GO:0032991],NA,"INDUCTION: Up-regulated during the transition from G1 to S phase of the cell cycle. The highest levels are observed in S phase, after which the levels decrease markedly. {ECO:0000269|PubMed:12361598}.","TISSUE SPECIFICITY: Highly expressed in testis. Detected at intermediate levels in spleen, thymus, prostate, small intestine, colon and peripheral blood leukocytes. {ECO:0000269|PubMed:12361598}."
33.807557906743,1.84944766602377,0.452621666865901,4.0860785097407,4.38725379948098e-5,0.0265955325324537,LOC132729883,lcl|NW_026865646.1_cds_XP_060571702.1_51102,132729883,equilibrative nucleobase transporter 1-like,XP_060571702.1,"complement(join(165384..165527,166570..166690,167489..167675,170598..170699,171018..171206,171432..171678,172408..172500,173567..173643,176068..176114,177191..177624))",CDS,sp|Q8NBI5|S43A3_HUMAN,Q8NBI5,S43A3,HUMAN,27.344,512,310,15,52,1557,18,477,1.63e-41,159,Q8NBI5,reviewed,S43A3_HUMAN,Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3),SLC43A3 ENBT1 PSEC0252,Homo sapiens (Human),491,GO:0015207; GO:0015208; GO:0015245; GO:0016323; GO:0035344; GO:0042910,hypoxanthine transport [GO:0035344],basolateral plasma membrane [GO:0016323]; adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910]; hypoxanthine transport [GO:0035344],adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910],basolateral plasma membrane [GO:0016323],NA,NA,"TISSUE SPECIFICITY: Widely expressed with highest levels in the liver and lung, followed by the pancreas (PubMed:26455426). Highly expressed in macrophages (Ref.1). {ECO:0000269|PubMed:26455426, ECO:0000269|Ref.1}."
637.2207481916,-1.19728575335796,0.263646485155794,-4.54125437193089,5.59205113583318e-6,0.00753311421898238,LOC132730403,lcl|NW_026865813.1_cds_XP_060572302.1_51632,132730403,coiled-coil domain-containing protein 112-like,XP_060572302.1,"join(130656..130676,132541..132638,133155..133276,133594..133683,134475..134550,135278..135467,136017..136103,136441..136590,138611..138838,139626..139775,140242..140337,140824..140945,141662..141692)",CDS,sp|Q8NEF3|CC112_HUMAN,Q8NEF3,CC112,HUMAN,40.135,446,258,6,130,1455,1,441,6.85e-79,256,Q8NEF3,reviewed,CC112_HUMAN,Coiled-coil domain-containing protein 112 (Mutated in bladder cancer protein 1),CCDC112 MBC1,Homo sapiens (Human),446,GO:0005737; GO:0034451,NA,centriolar satellite [GO:0034451]; cytoplasm [GO:0005737],NA,centriolar satellite [GO:0034451]; cytoplasm [GO:0005737],NA,NA,NA
52.1731323176173,-1.39774355546974,0.365501230580715,-3.8241828987798,1.31206491541498e-4,0.0470712857188949,LOC132730855,lcl|NW_026865957.1_cds_XP_060572912.1_52142,132730855,"NACHT, LRR and PYD domains-containing protein 3-like isoform X2",XP_060572912.1,"join(42544..42625,44026..46280)",CDS,sp|Q647I9|NALP5_BOVIN,Q647I9,NALP5,BOVIN,32.155,283,188,4,1336,2172,751,1033,1.67e-23,110,Q647I9,reviewed,NALP5_BOVIN,"NACHT, LRR and PYD domains-containing protein 5 (Mater protein homolog)",NLRP5 MATER NALP5,Bos taurus (Bovine),1098,GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005938; GO:0006887; GO:0007015; GO:0032880; GO:0040019; GO:0042585; GO:0048471; GO:0050727; GO:0051293; GO:0051302; GO:0051656; GO:0060471; GO:0060473; GO:0106333,actin filament organization [GO:0007015]; cortical granule exocytosis [GO:0060471]; establishment of organelle localization [GO:0051656]; establishment of spindle localization [GO:0051293]; exocytosis [GO:0006887]; positive regulation of embryonic development [GO:0040019]; regulation of cell division [GO:0051302]; regulation of inflammatory response [GO:0050727]; regulation of protein localization [GO:0032880],cell cortex [GO:0005938]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; subcortical maternal complex [GO:0106333]; ATP binding [GO:0005524]; actin filament organization [GO:0007015]; cortical granule exocytosis [GO:0060471]; establishment of organelle localization [GO:0051656]; establishment of spindle localization [GO:0051293]; exocytosis [GO:0006887]; positive regulation of embryonic development [GO:0040019]; regulation of cell division [GO:0051302]; regulation of inflammatory response [GO:0050727]; regulation of protein localization [GO:0032880],ATP binding [GO:0005524],cell cortex [GO:0005938]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; subcortical maternal complex [GO:0106333],NA,NA,"TISSUE SPECIFICITY: Oocyte-specific. {ECO:0000269|PubMed:15189828, ECO:0000269|PubMed:16339045}."
92.9706658255938,-1.05469088038214,0.221452411178584,-4.76260734651299,1.91107476326525e-6,0.00579246760745696,LOC132731011,lcl|NW_026866018.1_cds_XP_060573092.1_52337,132731011,uncharacterized protein LOC132731011,XP_060573092.1,"complement(join(237425..237531,238224..238408,240837..240888,241528..241672,243377..243547,244204..244292,244796..244933,246707..255377))",CDS,sp|Q8ND82|Z280C_HUMAN,Q8ND82,Z280C,HUMAN,39.474,114,67,2,8797,9135,285,397,3.26e-18,95.9,Q8ND82,reviewed,Z280C_HUMAN,Zinc finger protein 280C (Suppressor of hairy wing homolog 3) (Zinc finger protein 633),ZNF280C SUHW3 ZNF633,Homo sapiens (Human),737,GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0008270,regulation of DNA-templated transcription [GO:0006355],"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of DNA-templated transcription [GO:0006355]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",nucleus [GO:0005634],NA,NA,NA
85.4889921259933,-0.934446186181081,0.201309477673585,-4.64183900817748,3.45321879444274e-6,0.00753311421898238,LOC132731012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
654.873693080734,0.697550258484778,0.178661999961505,3.90430118679447,9.44980380019509e-5,0.0435993378821329,LOC132732296,lcl|NW_026866367.1_cds_XP_060574669.1_53756,132732296,"ATP-dependent 6-phosphofructokinase, muscle type-like isoform X1",XP_060574669.1,"join(10498..10645,16292..16365,17651..17728,18857..19046,19812..19977,20670..20714,22224..22332,22782..22877,25485..25577,26435..26560,27301..27365,29598..29676,35568..35714,39000..39053,46833..46903,47432..47522,49175..49327,50408..50572,51816..51880,54179..54393,55228..55333,56258..56396)",CDS,sp|Q867C9|PFKAM_HORSE,Q867C9,PFKAM,HORSE,62.402,766,263,5,106,2403,15,755,0,981,Q867C9,reviewed,PFKAM_HORSE,"ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)",PFKM,Equus caballus (Horse),780,GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0016020; GO:0030388; GO:0046872; GO:0061621; GO:0070095,"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]","6-phosphofructokinase complex [GO:0005945]; membrane [GO:0016020]; 6-phosphofructokinase activity [GO:0003872]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; metal ion binding [GO:0046872]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]",6-phosphofructokinase activity [GO:0003872]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; metal ion binding [GO:0046872],6-phosphofructokinase complex [GO:0005945]; membrane [GO:0016020],NA,NA,NA
221.228803227929,-1.00802741092747,0.268119817152928,-3.75961546457613,1.70174723285045e-4,0.0480890218009203,LOC132732829,lcl|NW_026866545.1_cds_XP_060575325.1_54350,132732829,"inositol 1,4,5-triphosphate receptor associated 2-like",XP_060575325.1,"complement(join(97693..97746,98499..98667,99379..99558,100181..100241,103492..103562,107801..107922,110090..110230))",CDS,sp|Q5RHB5|IRAG2_DANRE,Q5RHB5,IRAG2,DANRE,26.05,238,162,4,25,726,223,450,1.87e-11,67.8,Q5RHB5,reviewed,IRAG2_DANRE,"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein)",irag2 lrmp si:dkey-172o10.4,Danio rerio (Zebrafish) (Brachydanio rerio),1447,GO:0000785; GO:0005789; GO:0005813; GO:0007052; GO:0007344; GO:0031965; GO:0035046; GO:0051028; GO:0051984; GO:0072686; GO:0097431,mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; positive regulation of chromosome segregation [GO:0051984]; pronuclear fusion [GO:0007344]; pronuclear migration [GO:0035046],centrosome [GO:0005813]; chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear membrane [GO:0031965]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; positive regulation of chromosome segregation [GO:0051984]; pronuclear fusion [GO:0007344]; pronuclear migration [GO:0035046],NA,centrosome [GO:0005813]; chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear membrane [GO:0031965],"DEVELOPMENTAL STAGE: Expressed in embryos and early cleavage stages (at protein level). Maternally expressed. Expressed in early cleavage embryos, weakly at 4 hours post-fertilization (hpf) and undetected at 24 hpf. {ECO:0000269|PubMed:22542100}.",NA,NA
175.550808810041,-0.498038043220945,0.131791931772492,-3.77897217623832,1.57477016991583e-4,0.0478829759879629,LOC132732878,lcl|NW_026866557.1_cds_XP_060575388.1_54402,132732878,uncharacterized protein LOC132732878,XP_060575388.1,"complement(join(44179..44331,44703..44864,45719..45788,46230..46457,46777..46967,49064..49201,50807..50921,51354..51463,52863..52970,53198..53267,54302..54381,54836..54893,55660..55910,56574..56715,57297..57415,57886..58120,58741..59186,59608..59733,60062..60871,62617..62656,65322..67917,68008..74043,74534..74727,75301..75520,76371..76517,77626..77711,78537..78621,80051..80155,82542..82639,86835..86982,87452..87530,88909..88990,91592..91666,96648..96834,103438..103576))",CDS,sp|Q61493|REV3L_MOUSE,Q61493,REV3L,MOUSE,55.478,1004,372,9,10921,13920,2190,3122,0,1164,Q61493,reviewed,REV3L_MOUSE,DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4),Rev3l Polz Sez4,Mus musculus (Mouse),3122,GO:0000166; GO:0003677; GO:0003887; GO:0005730; GO:0006260; GO:0006281; GO:0008270; GO:0016035; GO:0042276; GO:0051539,DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276],"nucleolus [GO:0005730]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]","4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",nucleolus [GO:0005730]; zeta DNA polymerase complex [GO:0016035],NA,NA,NA
23.2718868826658,2.19376096595473,0.528932720534026,4.14752364675008,3.36090766218949e-5,0.0214461286823081,LOC132733016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
27.8616413662203,1.42095980403502,0.373245042485029,3.80704267248779,1.40638485714149e-4,0.0470712857188949,LOC132737163,lcl|NW_026853544.1_cds_XP_060580397.1_7039,132737163,acyl-CoA dehydrogenase family member 10-like,XP_060580397.1,"join(<339..476,899..989,1428..1586,1897..2069,2653..2796,4311..4388,11948..12094)",CDS,sp|Q8K370|ACD10_MOUSE,Q8K370,ACD10,MOUSE,68.285,309,98,0,1,927,753,1061,9.15e-154,460,Q8K370,reviewed,ACD10_MOUSE,Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-),Acad10,Mus musculus (Mouse),1069,GO:0005739; GO:0016627; GO:0046395; GO:0050660,carboxylic acid catabolic process [GO:0046395],"mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; carboxylic acid catabolic process [GO:0046395]","flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",mitochondrion [GO:0005739],NA,NA,NA
3522.60488978509,-1.0144415303327,0.265763742150036,-3.81708024625872,1.35040259073913e-4,0.0470712857188949,LOC132737737,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3973.583533813,-0.61454781081621,0.157008051623015,-3.91411653392003,9.07358094079313e-5,0.0435993378821329,LOC132741452,lcl|NW_026854897.1_cds_XP_060585598.1_11743,132741452,rho GTPase-activating protein gacU-like isoform X2,XP_060585598.1,"join(126354..126482,128439..128521,128932..129028,129788..130156,130553..130754,131846..132092,132483..132574,132919..133048,135565..135664,139118..141625)",CDS,sp|Q80Y19|RHGBA_MOUSE,Q80Y19,RHGBA,MOUSE,30.663,362,206,9,97,1149,22,349,3.24e-32,140,Q80Y19,reviewed,RHGBA_MOUSE,Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A),Arhgap11a Kiaa0013,Mus musculus (Mouse),987,GO:0005096; GO:0005634; GO:0007165; GO:0043547,positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],GTPase activator activity [GO:0005096],nucleus [GO:0005634],NA,NA,NA
55.9489305020698,3.54994839148278,0.781687181665724,4.54139261170699,5.5883849783775904e-06,0.00753311421898238,LOC132741641,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
68.1803000549294,-1.49340824684901,0.343469072013416,-4.34801374719024,1.37375995394881e-5,0.0118967612011967,LOC132742068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
68.5447053034062,1.1500606022464,0.298709470142367,3.85009756034274,1.18070784889127e-4,0.0470712857188949,LOC132745166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
194.308462821567,1.03158608650506,0.27644009289419,3.73168043645505,1.90206696301665e-4,0.0483503376207715,LOC132745762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
301.203554145315,-1.23420785867673,0.271457177125262,-4.54660242085704,5.45188452513593e-6,0.00753311421898238,LOC132745822,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
675.013468349586,-0.376723319803155,0.0935907691742836,-4.02521875957259,5.69223741424345e-5,0.0313694029137671,LOC132746012,lcl|NW_026856260.1_cds_XP_060591040.1_16615,132746012,vasculin-like protein 1 isoform X2,XP_060591040.1,"join(304741..304812,305335..305485,306421..306635,307343..307558,307946..308021,308933..309042,313872..313991,314475..314578,315053..315299)",CDS,sp|Q3KR53|GPBL1_RAT,Q3KR53,GPBL1,RAT,34.286,175,83,7,796,1230,281,453,4.2e-14,77.8,Q3KR53,reviewed,GPBL1_RAT,Vasculin-like protein 1 (GC-rich promoter-binding protein 1-like 1),Gpbp1l1,Rattus norvegicus (Rat),475,GO:0003677; GO:0003723; GO:0005634; GO:0006351; GO:0006355; GO:0045893,DNA-templated transcription [GO:0006351]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; DNA-templated transcription [GO:0006351]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355],DNA binding [GO:0003677]; RNA binding [GO:0003723],nucleus [GO:0005634],NA,NA,NA
111.575789849726,-1.34462019430879,0.25378949642286,-5.29817117438305,1.16968288952196e-7,0.00141812353525643,LOC132746399,lcl|NW_026856403.1_cds_XP_060591504.1_17037,132746399,FYVE and coiled-coil domain-containing protein 1-like,XP_060591504.1,"join(244740..244917,245325..245444,245898..246010,246523..246629,247547..247690,247893..247977,248382..248641,249111..249467,249688..249820,250936..252438,252627..255905,256338..256472,257153..257224,258924..258971,259772..259890,260508..260646,261012..261085,261674..261849,262517..262718,263987..264106,265802..265961,266730..266899,267500..267557)",CDS,sp|Q8VDC1|FYCO1_MOUSE,Q8VDC1,FYCO1,MOUSE,52.907,172,81,0,157,672,12,183,1.43e-58,228,Q8VDC1,reviewed,FYCO1_MOUSE,FYVE and coiled-coil domain-containing protein 1,Fyco1,Mus musculus (Mouse),1437,GO:0005764; GO:0005770; GO:0005776; GO:0005794; GO:0008270; GO:0072383; GO:1901098,plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098],autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; zinc ion binding [GO:0008270]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098],zinc ion binding [GO:0008270],autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764],NA,NA,"TISSUE SPECIFICITY: Expressed in heart and testis. Expressed in the eye lens. {ECO:0000269|PubMed:12461651, ECO:0000269|PubMed:21636066}."
157.617392946071,-0.631967762605412,0.162137036116074,-3.89773846706428,9.70951932380063e-5,0.0435993378821329,LOC132746437,lcl|NW_026856414.1_cds_XP_060591559.1_17085,132746437,uncharacterized protein LOC132746437,XP_060591559.1,"join(368595..369544,370510..374002)",CDS,sp|Q9C0G0|ZN407_HUMAN,Q9C0G0,ZN407,HUMAN,34.314,408,243,7,2515,3708,1405,1797,1.81e-61,237,Q9C0G0,reviewed,ZN407_HUMAN,Zinc finger protein 407,ZNF407 KIAA1703,Homo sapiens (Human),2248,GO:0003677; GO:0005634; GO:0008270; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],nucleus [GO:0005634],NA,NA,NA
84.1093089255687,-1.09799527280417,0.216221296548075,-5.07810881875846,3.81210348906371e-7,0.00231089713507042,LOC132746792,lcl|NW_026856504.1_cds_XP_060592026.1_17503,132746792,phospholipase D1-like,XP_060592026.1,"join(77330..77358,82391..82548,87950..88112,100183..100311,103876..104011,110441..110506,111677..111834,122931..>123083)",CDS,sp|Q9Z280|PLD1_MOUSE,Q9Z280,PLD1,MOUSE,37.086,302,169,7,97,990,19,303,8.56e-43,161,Q9Z280,reviewed,PLD1_MOUSE,Phospholipase D1 (PLD 1) (mPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1),Pld1,Mus musculus (Mouse),1074,GO:0000139; GO:0004630; GO:0005768; GO:0005789; GO:0005794; GO:0006654; GO:0008654; GO:0016042; GO:0031902; GO:0035091; GO:0035556; GO:0048471; GO:0050830,defense response to Gram-positive bacterium [GO:0050830]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654],endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; defense response to Gram-positive bacterium [GO:0050830]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654],phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630],endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471],DEVELOPMENTAL STAGE: Expressed most strikingly in selected ventricular cells lining the spinal cord and brain. The level of expression decreases dramatically as the cells differentiate into neurons and migrate to the outer layer of the spinal cord and brain. Expression is observed during development in a restricted region of the nasal neuroepithelium.,NA,"TISSUE SPECIFICITY: Expressed in kidney, lung, and at a much lower levels, in brain, liver, heart, testis and spleen."
84.1607943008413,1.47002990326604,0.386456090698745,3.80387303667048,1.42451211235297e-4,0.0470712857188949,LOC132747103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
133.466509053986,-1.15536033165681,0.305797965077016,-3.77818188347275,1.57977485938512e-4,0.0478829759879629,LOC132747234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
119.383445117869,-1.3230293747428,0.306861576138257,-4.31148595204605,1.62161078588101e-5,0.0131069394453476,LOC132749309,lcl|NW_026857301.1_cds_XP_060595016.1_20187,132749309,CST complex subunit TEN1-like,XP_060595016.1,7088..7465,CDS,sp|Q9D7K2|TEN1L_MOUSE,Q9D7K2,TEN1L,MOUSE,36.735,98,60,1,82,369,22,119,1.57e-15,71.6,Q9D7K2,reviewed,TEN1L_MOUSE,CST complex subunit TEN1 (Protein telomeric pathways with STN1 homolog) (Telomere length regulation protein TEN1 homolog),Ten1,Mus musculus (Mouse),161,GO:0000781; GO:0003697; GO:0005634; GO:1990879,NA,"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; nucleus [GO:0005634]; single-stranded DNA binding [GO:0003697]",single-stranded DNA binding [GO:0003697],"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; nucleus [GO:0005634]",NA,NA,NA
65.823857617885,-1.21125302677995,0.319155361520851,-3.79518307638025,1.47534547782746e-4,0.0470712857188949,LOC132752133,lcl|NW_026858111.1_cds_XP_060598402.1_23238,132752133,uncharacterized protein LOC132752133 isoform X4,XP_060598402.1,"join(9057..9062,21135..21267,25377..25530,36924..37119,40642..40657,45094..46415,48935..49043,49385..49524,50241..50385,50876..50959,51697..51840,69905..69999)",CDS,sp|Q071E0|KT5AA_DANRE,Q071E0,KT5AA,DANRE,48.235,85,34,3,250,486,261,341,2.09e-14,79.3,Q071E0,reviewed,KT5AA_DANRE,N-lysine methyltransferase KMT5A-A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A-A) (EC 2.1.1.361) (Lysine-specific methylase 5A-A) (SET domain-containing protein 8-A),kmt5aa set8a setd8 setd8a zgc:153719,Danio rerio (Zebrafish) (Brachydanio rerio),344,GO:0005634; GO:0005700; GO:0006357; GO:0009953; GO:0010628; GO:0032259; GO:0042054; GO:0042799; GO:0043516; GO:0051301; GO:0140944,"cell division [GO:0051301]; dorsal/ventral pattern formation [GO:0009953]; methylation [GO:0032259]; positive regulation of gene expression [GO:0010628]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of transcription by RNA polymerase II [GO:0006357]","nucleus [GO:0005634]; polytene chromosome [GO:0005700]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054]; cell division [GO:0051301]; dorsal/ventral pattern formation [GO:0009953]; methylation [GO:0032259]; positive regulation of gene expression [GO:0010628]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of transcription by RNA polymerase II [GO:0006357]",histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054],nucleus [GO:0005634]; polytene chromosome [GO:0005700],NA,NA,NA
725.551634974523,-0.77522704685199,0.20705287428349,-3.74410183647379,1.81040219194085e-4,0.0480890218009203,LOC132752300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
375.680317549199,-1.26578231724598,0.314072224926829,-4.03022686116507,5.57230463395693e-5,0.0313694029137671,LOC132757649,lcl|NW_026859722.1_cds_XP_060604961.1_29139,132757649,titin homolog,XP_060604961.1,complement(43806..54599),CDS,sp|D3ZQL6|MILK1_RAT,D3ZQL6,MILK1,RAT,56.075,107,47,0,1,321,1,107,4.31e-32,141,D3ZQL6,reviewed,MILK1_RAT,MICAL-like protein 1,Micall1,Rattus norvegicus (Rat),855,GO:0005770; GO:0005814; GO:0005929; GO:0006612; GO:0006897; GO:0006898; GO:0008093; GO:0010008; GO:0010009; GO:0015031; GO:0031175; GO:0031267; GO:0031902; GO:0032456; GO:0032458; GO:0036010; GO:0042802; GO:0046872; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0070300; GO:0097320; GO:1990090,cellular response to nerve growth factor stimulus [GO:1990090]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to cilium [GO:0061512]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; slow endocytic recycling [GO:0032458],centriole [GO:0005814]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic side of endosome membrane [GO:0010009]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267]; cellular response to nerve growth factor stimulus [GO:1990090]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to cilium [GO:0061512]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; slow endocytic recycling [GO:0032458],cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267],centriole [GO:0005814]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic side of endosome membrane [GO:0010009]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038],NA,NA,NA
401.175360310328,-0.682398858153362,0.162768929107439,-4.19243931808957,2.75970914462452e-5,0.0185881742607931,LOC132758254,lcl|NW_026859905.1_cds_XP_060605796.1_29882,132758254,golgin subfamily A member 3-like isoform X2,XP_060605796.1,"join(206368..206427,207012..207126,209746..209945,210656..210788,211181..211302,211499..214195,214443..214674,214893..215107,215660..215938,216330..216446,217263..217388,217681..217820,219713..219826,220455..220596)",CDS,sp|P55937|GOGA3_MOUSE,P55937,GOGA3,MOUSE,28.295,1085,746,9,1393,4584,394,1467,9.34e-93,335,P55937,reviewed,GOGA3_MOUSE,Golgin subfamily A member 3 (Golgin-160) (Male-enhanced antigen 2) (MEA-2),Golga3 Mea2,Mus musculus (Mouse),1487,GO:0000139; GO:0005793; GO:0007283; GO:0030154; GO:0032580,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139],NA,NA,"TISSUE SPECIFICITY: Highly expressed in testis. Transcripts can be found in spermatids during spermatogenesis. No expression in Leydig cells, spermatogonia or spermatocytes. Detected at low levels in all tissues."
1481.26307043342,-1.04004399499673,0.235553479084134,-4.41532003280346,1.00860661039906e-5,0.00940642041882937,LOC132758583,lcl|NW_026859998.1_cds_XP_060606255.1_30282,132758583,centromere-associated protein E-like,XP_060606255.1,"complement(join(245327..245490,246081..246157,247016..247209,248766..248899,249661..249758,250412..250511,251120..251294,251780..251872,252265..252324,255931..256029,256707..257126,258672..259526,259948..260115,260879..261009,262180..265171,265711..265834,266702..266918,272674..272734,272956..273111,274001..274123,274889..275021,276915..277045,277748..277804,278508..278575,279355..279439,280053..280163,280778..280896,281875..281964,283895..283998,290312..290367))",CDS,sp|Q02224|CENPE_HUMAN,Q02224,CENPE,HUMAN,46.189,433,216,8,1,1266,1,427,1e-98,361,Q02224,reviewed,CENPE_HUMAN,Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin-7) (Kinesin-related protein CENPE),CENPE,Homo sapiens (Human),2701,GO:0000278; GO:0000775; GO:0000776; GO:0000779; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0008017; GO:0015630; GO:0016020; GO:0030071; GO:0030496; GO:0043231; GO:0043515; GO:0045171; GO:0045860; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0072686; GO:0099606; GO:0099607; GO:1990023,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071],"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]",ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle midzone [GO:0051233]",NA,NA,NA
88.8585080265999,-0.877769534153985,0.228352833870588,-3.84391784974051,1.21085553812328e-4,0.0470712857188949,LOC132758975,lcl|NW_026860124.1_cds_XP_060606675.1_30672,132758975,uncharacterized protein LOC132758975,XP_060606675.1,"complement(join(<3931..4038,5073..5309,8545..10247,29897..30115))",CDS,sp|Q9C0D7|ZC12C_HUMAN,Q9C0D7,ZC12C,HUMAN,52.761,163,70,1,1798,2265,210,372,1.06e-44,176,Q9C0D7,reviewed,ZC12C_HUMAN,Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C),ZC3H12C KIAA1726 MCPIP3,Homo sapiens (Human),883,GO:0003729; GO:0004521; GO:0005634; GO:0008270; GO:0036464,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270],mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270],cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634],NA,INDUCTION: By cytokines (TNF-alpha and interleukin-1) in acute monocytic leukemia cell line THP-1 cells. {ECO:0000269|PubMed:18178554}.,NA
136.791974558403,-1.13948058052997,0.304499278236305,-3.74214542356215,1.82455872883729e-4,0.0480890218009203,LOC132759052,lcl|NW_026860152.1_cds_XP_060606759.1_30744,132759052,E3 ubiquitin-protein ligase Bre1-like,XP_060606759.1,"join(958..963,1745..1846,3647..3823)",CDS,sp|Q9VRP9|BRE1_DROME,Q9VRP9,BRE1,DROME,74.468,94,23,1,1,279,950,1043,6.51e-45,157,Q9VRP9,reviewed,BRE1_DROME,E3 ubiquitin-protein ligase Bre1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Bre1) (dBre1),Bre1 CG10542,Drosophila melanogaster (Fruit fly),1044,GO:0000785; GO:0005634; GO:0006325; GO:0006513; GO:0007219; GO:0008270; GO:0031452; GO:0033503; GO:0045893; GO:0061630,chromatin organization [GO:0006325]; negative regulation of heterochromatin formation [GO:0031452]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; protein monoubiquitination [GO:0006513],chromatin [GO:0000785]; HULC complex [GO:0033503]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; negative regulation of heterochromatin formation [GO:0031452]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; protein monoubiquitination [GO:0006513],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],chromatin [GO:0000785]; HULC complex [GO:0033503]; nucleus [GO:0005634],NA,NA,NA
133.107178543439,-0.86886625619526,0.174823137930986,-4.96997289076379,6.69622633460256e-7,0.00270616826935738,LOC132759372,lcl|NW_026860247.1_cds_XP_060607120.1_31071,132759372,golgin subfamily A member 1-like,XP_060607120.1,"join(234634..234754,235718..235785,236322..236412,236623..236697,238308..238405,238920..239048,239570..239685,240043..240154,242101..242196,242843..242971,243341..243436,243911..244006,244652..244747,245526..245678,246354..246449,247154..247346,247977..248137,248932..249042,249570..250097,251037..251201)",CDS,sp|Q92805|GOGA1_HUMAN,Q92805,GOGA1,HUMAN,51.948,77,35,1,2500,2724,691,767,2.86e-17,90.9,Q92805,reviewed,GOGA1_HUMAN,Golgin subfamily A member 1 (Golgin-97),GOLGA1,Homo sapiens (Human),767,GO:0000139; GO:0001669; GO:0005794; GO:0005802; GO:0005829; GO:0048471,NA,acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],NA,acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],NA,NA,NA
26.5973231435926,2.1124787514721,0.474547575571349,4.4515636792132,8.52472447172949e-6,0.00939579631774985,LOC132759609,lcl|NW_026860302.1_cds_XP_060607404.1_31331,132759609,dermonecrotic toxin StSicTox-betaIB1i-like,XP_060607404.1,<1802..3133,CDS,sp|Q1W694|B1Q_LOXIN,Q1W694,B1Q,LOXIN,26.263,297,167,14,13,852,33,294,5.04e-10,64.3,Q1W694,reviewed,B1Q_LOXIN,Dermonecrotic toxin LiSicTox-betaID1 (EC 4.6.1.-) (Dermonecrotic toxin 5) (DT5) (LiRecDT5) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D 5) (SMD 5) (SMase D 5) (Sphingomyelinase D 5),NA,Loxosceles intermedia (Brown spider),305,GO:0004620; GO:0005576; GO:0006644; GO:0008081; GO:0016042; GO:0016829; GO:0031640; GO:0044398; GO:0046872; GO:0090729,envenomation resulting in induction of edema in another organism [GO:0044398]; killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],extracellular region [GO:0005576]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; toxin activity [GO:0090729]; envenomation resulting in induction of edema in another organism [GO:0044398]; killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],lyase activity [GO:0016829]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; toxin activity [GO:0090729],extracellular region [GO:0005576],NA,NA,TISSUE SPECIFICITY: Expressed by the venom gland. {ECO:0000305|PubMed:17296256}.
1278.92076099619,-0.742672472741893,0.192328411151333,-3.86148083008663,1.12701856427271e-4,0.0470712857188949,LOC132759803,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
420.936190413842,-0.700063683788513,0.187680894967141,-3.73007430463863,1.91423309617043e-4,0.0483503376207715,LOC132760592,lcl|NW_026860555.1_cds_XP_060608579.1_32388,132760592,coiled-coil domain-containing protein 178-like,XP_060608579.1,"complement(join(94082..94396,94924..95073,95268..95341,96245..96330,96653..96798,98608..98721,99281..99373,105705..105836,106484..106667,107348..107484,108154..108249,108965..109118,110169..110311,110925..110994,112408..112558,112859..113065,113588..113725,114171..114365,114796..114837,115278..115437))",CDS,sp|Q5BJE1|CC178_HUMAN,Q5BJE1,CC178,HUMAN,26.106,226,120,3,253,897,82,271,2.84e-13,78.2,Q5BJE1,reviewed,CC178_HUMAN,Coiled-coil domain-containing protein 178,CCDC178 C18orf34,Homo sapiens (Human),867,GO:0036064,NA,ciliary basal body [GO:0036064],NA,ciliary basal body [GO:0036064],NA,NA,NA
